CDC warns of rising extensively drug-resistant shigella infections

14 articles · Updated · The New York Times · Apr 24

Extensively drug-resistant shigella strains accounted for 8.5% of U.S. infections by 2023, up from zero in 2011, according to the CDC.
These XDR strains do not respond to the five main antibiotics typically used for severe cases, complicating treatment options.
While less than 10% of cases are drug-resistant, experts note most of the 450,000 annual U.S. infections resolve without antibiotics, but the rapid rise in resistance is concerning.

How did a once-treatable stomach bug evolve into a drug-resistant threat in just a decade?

As superbugs surge worldwide, are we witnessing the beginning of the end for antibiotics?

Why has this superbug shifted from infecting children to primarily targeting adult men?

With no oral antibiotics left, is 'bacteria-eating' phage therapy our best hope against this superbug?

Could your gut already be hosting the genes that will create the next untreatable infection?

How can you tell if diarrhea is a simple bug or this untreatable XDR shigella?